ArticleBrain, behavior, and immunity2026
Lipocalin-2 perpetuates postoperative and post-infectious neuroinflammation and anxiety-like behavior.
Article in Brain, behavior, and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Lipocalin-2 (LCN2) is a pleiotropic cytokine with well-established roles in immune defense, iron metabolism, and inflammation that has been used as a biomarker for kidney injury, cancer, and infection. Recent work has also suggested a role for LCN2 in brain function and behavior, suggesting that LCN2 excess could be a driver of neuropsychiatric complications of infectious and inflammatory conditions. Here, we show that LCN2 levels remain elevated in both the brain and circulation for weeks after an acute infection or simple laparotomy in male and female mice. We used an inducible knockout mouse model to decrease lcn2 expression after recovery from surgery and infection and found that higher brain lcn2 RNA levels predicted persistent neuroinflammation and anxiety-like behavior in survivors. Exogenous LCN2 administration increased in vivo activity of hippocampal CA1 pyramidal cells and increased anxiety-like behavior in male mice. Together, these findings reveal a novel role for LCN2 as a neuroinflammatory mediator of long-term neuropsychiatric dysfunction in infection survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.